Both in Biotechnology
ADMA Biologics vs BioCryst Pharmaceuticals
Over the past year ADMA returned −27.7% and BCRX returned +24.9%; their daily moves had a correlation of 0.21.
ADMA −27.7% BCRX +24.9%Growth of $1, one year, split-adjusted
| Metric | ADMA | BCRX |
|---|---|---|
| Price | $11.11 | $8.57 |
| Market cap | $2.49B | $2.19B |
| Today | +0.45% | +3.94% |
| 1 month | +9.9% | +5.8% |
| 6 months | +8.4% | −5.1% |
| Year to date | −39.1% | +9.9% |
| 1 year | −28.2% | +17.1% |
| Revenue growth (YoY) | +2.0% | +33.6% |
| Gross margin | 69.4% | 98.2% |
| Net margin | 30.4% | 35.9% |
| P/E (TTM) | 14.7× | — |
| Price / sales | 4.9× | 2.3× |
| Net cash | -$60.6M | -$471.6M |
| Dividend yield | — | — |
| Volatility (60d) | 38.5% | 44.9% |
| Short % of float | 9.1% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).